At this point its unclear why anyone would pay higher multiple than the company is worth. And second thing - listing in HK obviously takes solid time. How is it in Sweden? Also they still havent made it to even Swedish OTC market, why spinoff should be easier?
Anyway I look at it, it totally dependent on the ability to list in Sweden as SIAF first.